Tianfeng Securities assigns a buy rating to Ketuo Bio: Probiotics business maintains a high growth trend, and R&D barriers are built to lead the industry – yqqlm

  • Post date April 29, 2022 — 12:40 Post Lock Login to View

Key Data Concepts:   
? These are the company names, stock quotes, topics, and entities related to this data.

300858 ADD Industry Beijing Scitop Bio-tech Tianfeng Securities Science, Technology Research, Development Financial, Business Service Paper, Packaging Product Currency Market, Exchange Securities Trend Espionage, Intelligence Technology, Engineering Series Economy, Business, Finance

Full Data

?
UNLOCK DATA
Subscribe & Access the Best Data and Intelligence on the Chinese Stock Markets


Join Now!

Need this critical market data?

Access thousands of market events, data points, and news articles!


Already have an account?
Login



Related Data